BFM
TECH icon

Boothbay Fund Management’s Bio-Techne TECH Stock Holding History

Boothbay Fund Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,000
Closed -$2.35M – 2478
2025
Q4 		$2.35M Buy
+40,000
New +$2.43M 0.04% 514

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boothbay Fund Management's TECH Position: Q2 2026 in Review

Boothbay Fund Management increased its Bio-Techne (TECH) stake by 13% in Q2 2026, buying an estimated $451K and bringing the position to 73,555 shares worth $5.2M. The position accounts for 0.07% of the portfolio, ranked #341.

Boothbay Fund Management first reported a position in TECH in Q2 2021 and has held it in 11 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Boothbay Fund Management held 73,555 shares of Bio-Techne worth $5.2M as of Q2 2026.
  • Boothbay Fund Management bought 8,345 Bio-Techne shares in Q2 2026, an estimated $451K.
  • Bio-Techne made up 0.07% of Boothbay Fund Management's portfolio in Q2 2026, its #341 holding.
  • Boothbay Fund Management first reported a position in Bio-Techne in Q2 2021 and has held it in 11 quarters since.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.